Serum Soluble CD163 as a Predictor of Esophageal Varices and Variceal Bleeding in Cirrhotic Patients
Rizk, M., Hussein, A., Afifi, M., Amer, A. (2021). Serum Soluble CD163 as a Predictor of Esophageal Varices and Variceal Bleeding in Cirrhotic Patients. EKB Journal Management System, 83(1), 1629-1637. doi: 10.21608/ejhm.2021.175171
Mahmoud Rizk; Ahmed Mohamed Hussein; Mohamed Abd Ellatif Afifi; Amany A. Amer. "Serum Soluble CD163 as a Predictor of Esophageal Varices and Variceal Bleeding in Cirrhotic Patients". EKB Journal Management System, 83, 1, 2021, 1629-1637. doi: 10.21608/ejhm.2021.175171
Rizk, M., Hussein, A., Afifi, M., Amer, A. (2021). 'Serum Soluble CD163 as a Predictor of Esophageal Varices and Variceal Bleeding in Cirrhotic Patients', EKB Journal Management System, 83(1), pp. 1629-1637. doi: 10.21608/ejhm.2021.175171
Rizk, M., Hussein, A., Afifi, M., Amer, A. Serum Soluble CD163 as a Predictor of Esophageal Varices and Variceal Bleeding in Cirrhotic Patients. EKB Journal Management System, 2021; 83(1): 1629-1637. doi: 10.21608/ejhm.2021.175171

Serum Soluble CD163 as a Predictor of Esophageal Varices and Variceal Bleeding in Cirrhotic Patients

The Egyptian Journal of Hospital Medicine
Article 125, Volume 83, Issue 1, April 2021, Page 1629-1637  XML PDF (528.46 K)
Document Type: Original Article
DOI: 10.21608/ejhm.2021.175171
View on SCiNiTO View on SCiNiTO
Authors
Mahmoud Rizk email orcid 1; Ahmed Mohamed Hussein2; Mohamed Abd Ellatif Afifi2; Amany A. Amer3
1Internal Medicine Department, Gastroenterology and hepatology unit, Faculty of Medicine, Benha University, Egypt
2Department of Internal Medicine, Hepatology and Gastroenterology Unit, Benha University, Egypt
3Department of Tropical Medicines, Faculty of Medicine, Menoufia University, Egypt
Abstract
ABSTRACT
Background: Bleeding of esophageal varices (OV) is also bearing elevated mortality in patients with liver cirrhosis (LC). The best standard diagnostic investigation for OV is upper gastrointestinal (GI) endoscopy. Patients and endoscopic units alike are burdened by the endoscopic screening of all patients with liver cirrhosis. The use of non-invasive OV detection reduces the need for endoscopic screening.
Objective: The aim of the current work was to test serum soluble CD 163(sCD163) as a predictor of the presence, and grade of OV and as non-invasive indicator of having severe variceal bleeding.
Patients and Methods: This cross-sectional study included a total of 70 cirrhotic patients, attending at the Hepatology and Gastroenterology Unit, Department of Internal Medicine, Benha University Hospital, Egypt. To detect OV, all patients underwent upper GI endoscopy, and serum sCD163 levels were assessed using an ELISA technique.
Results: Patients with OV had a higher mean value of sCD163 levels (8.71±8.42 ng/ml) than patients without OV (2.89±1.02 ng/ml), however this was not statistically significant (P=0.13). sCD163 level was significantly higher in large OV group (10.75±9.26 ng/ml) than small OV group (3.75±0.92 ng/ml), (P=0.001). The rate of significant variceal bleeding is closely linked to serum higher sCD163 levels more than (4.63 ng/ml).
Conclusion: It could be concluded that serum sCD163 could be a non-invasive indicator of the presence of OV in cirrhotic patients. It may also be used for the prediction of the size of OV and the probability of severe variceal bleeding.
 
 
Keywords
Serum soluble CD163; Esophageal varices; Variceal bleeding; Cirrhotic patients
Statistics
Article View: 128
PDF Download: 319